Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Blood

• Publication date

  1989-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V74.1.26.BLOODJOURNAL74126PMID 2665836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.

  1989cited by this paper
• Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor.

  1988cited by this paper
• Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia

  1988cited by this paper
• Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.

  1988cited by this paper
• Modulation of surface CD11/CD18 glycoproteins (Mo1, LFA-1, p150,95) by human mononuclear phagocytes.

  1988cited by this paper
• Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo.

  1988cited by this paper
• Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy.

  1988cited by this paper
• Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.

  1988cited by this paper
• Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia.

  1988cited by this paper
• Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

  1988cited by this paper
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.

  1988cited by this paper
• Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.

  1988cited by this paper
• Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor.

  1988cited by this paper
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.

  1988cited by this paper
• Transient leucopenia induced by granulocyte-macrophage colony-stimulating factor.

  1987cited by this paper
• Hemopoietic responses in mice injected with purified recombinant murine GM-CSF.

  1987cited by this paper
• Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes.

  1987cited by this paper
• Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates

  1987cited by this paper
• Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-stimulating factor.

  1987cited by this paper
• Hematopoietic growth factors.

  1987cited by this paper
• Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF).

  1987cited by this paper
• Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

  1987cited by this paper
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.

  1987cited by this paper
• Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3.

  1986cited by this paper
• Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice.

  1986cited by this paper
• The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.

  1986cited by this paper
• Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes.

  1986cited by this paper
• Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

  1986cited by this paper
• Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF

  1986cited by this paper
• Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor.

  1986cited by this paper
• Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

  1986cited by this paper
• Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor.

  1985cited by this paper
• Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin.

  1985cited by this paper
• Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator

  1985cited by this paper
• Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.

  1985cited by this paper
• Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity.

  1982cited by this paper

• Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed mice

  2026cites this paper
• The Effect of Granulocyte Macrophage-Colony Stimulating Factor upon the Induction of Peripheral Blood Dendritic and Natural Killer Cells When Given Simultaneously with a Slow Continuous Doxorubicin Infusion

  2017cites this paper
• Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells

  2005cites this paper
• Hepatitis B Immunization of Healthy Elderly Adults: Relationship between Na¨ıve CD4+ T Cells and Primary Immune Response and Evaluation of GM-CSF as an Adjuvant

  2004cites this paper
• Phase I Trial of Granulocyte Macrophage-Colony Stimulating Factor and Interleukin-4 as a Combined Immunotherapy for Patients With Cancer

  2003cites this paper
• Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4.

  2002cites this paper
• Macrophage colony-stimulating factor restored chemotherapy-induced granulocyte dysfunctions: role of IL-8 production by monocytes.

  2002cites this paper
• Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.

  2000cites this paper
• Granulocyte Macrophage Colony-stimulating Factor and Interleukin 4 Enhance the Number and Antigen-presenting Activity of Circulating CD 14 1 and CD 83 1 Cells in Cancer Patients 1

  2000cites this paper
• Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin.

  1999cites this paper
• Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis

  1999cites this paper
• Comparison of Cytokines in Children with Recurrent Solid Tumors Treated with Intensive Chemotherapy

  1998cites this paper
• Leukemia Cells and the Cytokine Network

  1998cites this paper
• Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor

  1998cites this paper
• Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A.

  1998cites this paper
• Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.

  1998cites this paper
• Differentiated KU-812 Cell Line Are Inhibited by Mouse Bone Marrow Mast Cells and the Short-Term and Long-Term Cytokine Release

  1998cites this paper
• Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Antitumor Activity of Interleukin-12 in Melanoma Model in Mice

  1998cites this paper
• In vitro effects of recombinant human granulocyte-macrophage colony-stimulating factor (RhGM-CSF) on polymorphonuclear cell (PMN) and monocyte (MO) functional capacities in ovarian cancer patients versus human volunteers.

  1997cites this paper
• Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications

  1997cites this paper
• A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer

  1996cites this paper
• Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients.

  1996cites this paper
• Tolerability and efficacy of GM-CSF [Leucomax] in patients with small cell lung cancer treated with intensive chemotherapy

  1996cites this paper
• Megakaryocytopoiesis: cellular aspects and regulation.

  1995cites this paper
• Granulocyte‐macrophage‐colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study

  1995cites this paper
• Granulocyte growth factors: achieving a consensus.

  1995cites this paper
• Adeno-associated virus 2-mediated gene transfer and functional expression of the human granulocyte-macrophage colony-stimulating factor.

  1995cites this paper
• The effect of granulocyte‐macrophage colony‐stimulating factor on myeloid cells and its clinical applications

  1995cites this paper
• Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.

  1995cites this paper
• American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.

  1994cites this paper
• The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenism.

  1994cites this paper
• G‐ and GM‐CSF in oncology and oncological haematology

  1994cites this paper
• Improvement of host defenses with hemopoietic growth factors.

  1994cites this paper
• Colony-Stimulating Factors in Leukopoiesis

  1993cites this paper
• Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy.

  1993cites this paper
• Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.

  1993cites this paper
• [Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors].

  1993cites this paper
• Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects.

  1993cites this paper
• High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.

  1993cites this paper
• Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.

  1993cites this paper
• Adult T cell leukemia associated with eosinophilia: analysis of eosinophil-stimulating factors produced by leukemic cells.

  1992cites this paper
• Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates.

  1992cites this paper
• Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.

  1992cites this paper
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.

  1992cites this paper
• Cytokine regulation of bone marrow natural suppressor cell activity in the suppression of lymphocyte function.

  1992cites this paper
• Biology and clinical applications of hemopoietins in pediatric practice.

  1992cites this paper
• Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor — hematological response accompanied by pulmonary complications with lethal outcome

  1992cites this paper
• Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigations.

  1992cites this paper
• Phase I study of subcutaneously-administered bacterially-synthesised recombinant human granulocyte-macrophage colony-stimulating factor.

  1992cites this paper
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor

  1992cites this paper
• Granulocyte-macrophage colony-stimulating factor: present status.

  1992cites this paper
• Identification and characterization of a nucleotide binding site on recombinant murine granulocyte/macrophage-colony stimulating factor.

  1992cites this paper
• Granulocyte‐macrophage colony‐stimulating factor: Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin

  1992cites this paper
• A clinical investigation on the patients who died of a malignancy in the jaws and oral cavity

  1992cites this paper
• The effects of myeloid growth factors on phagocyte-endothelium interactions.

  1992cites this paper
• Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF)

  1992cites this paper
• Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

  1992cites this paper
• The clinical use of colony stimulating factors.

  1991cites this paper
• Hematopoietic growth factors.

  1991cites this paper
• The Granulocyte/Macrophage-Colony Stimulating Factor (GM-CSF): Basic Science and Clinical Application

  1991cites this paper
• Granulocyte-monocyte and Granulocyte-Colony Stimulating Factors in Myelodysplastic Syndromes.

  1991cites this paper
• Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.

  1991cites this paper
• A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.

  1991cites this paper
• Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.

  1991cites this paper
• Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors.

  1991cites this paper
• Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice.

  1991cites this paper
• Granulocytopenia in Cancer Patients Treated in a Phase I Trial with Recombinant Human Tumor Necrosis Factor

  1991cites this paper
• The Current Status of Myeloid Growth Factor Therapy

  1991cites this paper
• Differential dose‐related haematological effects of GM‐CSF in pancytopenia: evidence supporting the advantage of low‐ over high‐dose administration in selected patients

  1991cites this paper
• Potential uses of recombinant human granulocyte-macrophage colony-stimulating factor in children.

  1991cites this paper
• Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates.

  1991cites this paper
• Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Related Neutropenia in Patients with Non-Hodgkin's Lymphomas-A Phase I/II Study of Dose and Mode of Administration.

  1991cites this paper
• The role of colony-stimulating factors in bone marrow transplantation.

  1991cites this paper
• Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial.

  1990cites this paper
• Hematopoietic growth factors: overview and clinical applications, Part III.

  1990cites this paper
• Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

  1990cites this paper
• Granulocyte-macrophage colony-stimulating factor: more than a hemopoietin.

  1990cites this paper
• G-CSF and GM-CSF in clinical trials.

  1990cites this paper
• Hematopoietic growth factors: overview and clinical applications, Part II.

  1990cites this paper
• Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.

  1990cites this paper
• The potential role of granulocyte-macrophage colony stimulating factor (GM-CSF) in cancer chemotherapy.

  1990cites this paper
• In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.

  1990cites this paper
• In vivo stimulation of megakaryocytopoiesis by recombinant murine granulocyte-macrophage colony-stimulating factor.

  1990cites this paper
• Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.

  1989cites this paper